Danske Bank’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.1M Buy
890,499
+131,663
+17% +$11.8M 0.18% 97
2026
Q1
$54.5M Sell
758,836
-169,626
-18% -$13.1M 0.13% 141
2025
Q4
$73.7M Buy
928,462
+113,009
+14% +$8.91M 0.17% 110
2025
Q3
$61.5M Sell
815,453
-159,120
-16% -$10.9M 0.15% 119
2025
Q2
$67.2M Buy
974,573
+444,095
+84% +$29.1M 0.17% 112
2025
Q1
$35.9M Sell
530,478
-94,530
-15% -$5.66M 0.11% 161
2024
Q4
$28.1M Buy
625,008
+93,730
+18% +$5.26M 0.08% 208
2024
Q3
$33.4M Buy
531,278
+14,700
+3% +$858K 0.11% 166
2024
Q2
$30.5M Sell
516,578
-45,087
-8% -$2.82M 0.11% 160
2024
Q1
$44.8M Buy
+561,665
New +$42.9M 0.14% 135

Other funds holding CVS

Danske Bank's CVS Position: Q2 2026 in Review

Danske Bank increased its CVS Health (CVS) stake by 17% in Q2 2026, buying an estimated $11.8M and bringing the position to 890,499 shares worth $92.1M. The position accounts for 0.18% of the portfolio, ranked #97.

Danske Bank first reported a position in CVS in Q1 2024 and has held it in 10 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Danske Bank held 890,499 shares of CVS Health worth $92.1M as of Q2 2026.
  • Danske Bank bought 131,663 CVS Health shares in Q2 2026, an estimated $11.8M.
  • CVS Health made up 0.18% of Danske Bank's portfolio in Q2 2026, its #97 holding.
  • Danske Bank first reported a position in CVS Health in Q1 2024 and has held it in 10 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.